Cell penetrating peptides (CPPs) are short sequences often rich in cationic residues with the remarkable ability to cross cell membranes. In the past 20 years, CPPs have gained wide interest and have found numerous applications in the delivery of bioactive cargoes to the cytosol and even the nucleus of living cells. The covalent or non-covalent addition of hydrocarbon moieties to cationic CPPs alters the hydrophobicity/hydrophilicity balance in their sequence. Such perturbation dramatically influences their interaction with the cell membrane, might induce self-assembling properties and modifies their intracellular trafficking. In particular, the introduction of lipophilic moieties changes the subcellular distribution of CPPs and might result in a dramatically increase of the internalization yield of the co-transported cargoes. Herein, we offer an overview of different aspects of the recent findings concerning the properties of CPPs covalently or non-covalently associated to hydrocarbons. We will focus on the impact of the hydrocarbon moieties on the delivery of various cargoes, either covalently or non-covalently bound to the modified CPPs. We will also provide some key elements to rationalize the influence of the hydrocarbons moieties on the cellular uptake. Furthermore, the recent in vitro and in vivo successful applications of acylated CPPs will be 2 summarized to provide a broad view of the versatility of these modified CPPs as small-molecules and oligonucleotides vectors.
Introduction
Small molecule-based drugs have been very successful over the past 60 years in interfering with biological processes. Despite the considerable size of the chemical space and the always growing-up savoir-faire of chemists, the selectivity of these small molecules remains low. [1, 2] Moreover, numerous breakthroughs in basic biological research and the unprecedented investment in pharmaceutical research were not sufficient to induce a growing-up drug release on the market. [3] Many very promising bioactive molecules that were recently discovered, as small interfering RNAs (siRNAs), could have tremendous therapeutic applications, [4] but, like others biomacromolecules, the poor bioavailability and rapid degradation in the bloodstream hamper their therapeutic application. The difficulty to cross the plasma membrane and/or the blood-brain barrier (BBB) to reach their target is also an issue. To transform siRNAs into a drug requires developing efficient delivery strategies to fill the gap between benches and beds.
Due to their intrinsic gene delivery ability, viral vectors were developed up to clinical trials. But, the attractiveness of such delivery agents has decreased after several accidents. [5] Safer gene delivery strategies still need to be developed. For in vitro use, a large diversity of cationic lipids has been used. They share common features: a headgroup, made of several charged nitrogen atoms, is associated via a spacer to long hydrocarbon chains (from 14 carbon atoms). The charged nitrogen atoms promote electrostatic interactions with the anionic phosphate groups of the oligonucleotide while the spacer might have a non-negligible effect (organization, size, hydrophobic interactions with the oligonucleotide). These cationic lipids are formulated with a neutral co-lipid to form unilamellar vesicles, which form lipoplexes when mixed with the oligonucleotide to be delivered. One of this formulation, named LipofectAMINE ® (Figure 1 A) is widely used for in vitro transfection. [6] High transfection efficiencies have been reported, but many cell types remain difficult to transfect (primary cultured cells) and the cell viability is often reduced after the transfection step. The efficiency of delivery has to be improved, both for in vitro and in vivo applications. cross the plasma membrane (formation of pores, the carpet mechanism, transitory formation of inverted micelles inside the bilayer, on the left). The pathways mediated by the cell machinery (macropinocytosis and endocytosis, on the right) confine the CPP inside endosomes, where CPP have to escape. C) Model of CPP direct translocation via the formation of inverted micelles. [7, 8] CPPs have to dimerize prior to the formation of the inverted micelle.
The first cell penetrating peptides (CPPs) that were discovered, Penetratin and Tat, are short natural cationic sequences that are spontaneously able to enhance the penetration of proteins into living cells (Table 1) . [9, 10] Soon after their identification, they have been used to promote the penetration of various exogenous cargoes through cell membranes, as small molecules, peptides, proteins, oligonucleotides and even nanoparticles. [11] Interestingly, they exhibit a low cytotoxicity and immunogenicity. It is now widely accepted that these peptides enter both by energy-dependent (endocytosis, macropinocytosis) and energyindependent pathways ( Figure 1B ). [12] The role of phospholipids (PLs) in the direct translocation mechanism was soon underscored and it was hypothesized already in 1996, by Chassaing, Prochiantz et al.,
that CPPs translocate through cell-membranes as inverted micelles. [7] A very similar interpretation, named "mutual adaption" has been made by Wender et al. [13] In both models, hydrophilic cationic CPPs recruit the anionic PLs on the outer leaflet of the membrane bilayer. With these PLs, CPPs could transiently form a more lipophilic [(CPPs)(PLs)] complex, which can diffuse through the hydrophobic core of the membrane and deliver the CPPs to the inner leaflet of the membrane. The dissociation of the labile translocation complex delivers the CPP and its eventual cargo to the cytosol. (Figure 1 C) . [8, 14] Since the pioneer discoveries of Penetratin and Tat, the size of the family of CPPs never stopped growing.
Over the 15 past years, advances have been made in uncovering and designing new penetrating sequences.
For recent reviews on the development of the field of CPPs, [11, [18] [19] [20] [21] ] their internalization mechanisms, [14, [22] [23] [24] and pharmaceutical applications, [25, 26] see the indicated references.
Synthetic cationic penetrating sequence have been developed as the octa-or nonaarginine CPPs (Arg8 or Arg9, Figure 1 A and Table 1 ), directly inspired from the sequence of Tat, or TP10, which is a deletion analogue of the chimeric peptide Transportan (Table 1) . [15, 16] Cationic CPPs can efficiently deliver both in vitro and in vivo a broad diversity of bioactive cargoes across cell membranes and also across the BBB. For in vivo applications their enantiomers might be used to enhance the plasmatic half-life. Nevertheless, they still require several improvements to be widely applicable. In particular, the direct translocation pathway and/or the endosomal escape has(have) to be enhanced in order to successfully deliver most the cargo to the cytosolic or nuclear target. Moreover, CPPs often partially loose their delivery properties in the presence of serum or plasma.
Many hydrocarbon moieties have been covalently or non-covalently associated to the most common CPPs.
These hydrophobic entities dramatically change the physico-chemical properties of the cationic CPPs. In particular, their amphipathicity is profoundly transformed. Tat and oligoarginines are non-amphipathic and Penetratin is a secondary amphipathic peptide (in an α-helical conformation, Penetratin display one hydrophobic side and one cationic side, Table 1 ). Upon addition of a hydrophobic counterpart, these CPPs become primary amphipathic molecules (their primary structures contain well-defined cationic and hydrophobic domains) or even hydrophobic (in a water/chloroform biphasic mixture, they partition into chloroform). Turning non-amphipathic or secondary amphipathic peptides into primary amphipathic or hydrophobic molecules increases their affinity for neutral or weakly anionic membranes bilayers because they can interact both with the phosphate groups of the phospholipids and with the hydrophobic core of the membrane bilayer. [14, 27] This property is particularly interesting to enhance the local concentration of cargoes at the plasma membrane of eukaryotic cells and thus to favor their uptake by active transport.
Changes in the amphiphilicity of the CPPs will be discussed in more details all along this review.
Very interestingly, the addition of a hydrophobic moiety can also change the main internalization pathway of CPPs and enhance the direct translocation or the endosomal release of the cargo conjugated to the modified CPP. This is not surprising given the possible participation of these hydrophobic counterparts to the formation of inverted micelles (Figure 1 C) .
Besides the internalization of cargoes, the acylation of CPPs with long fatty acids presents also several advantages: it enhances the formation of stable CPP-oligonucleotides complexes, reduces their sensitivity to serum and protects oligonucleotides from enzymatic hydrolysis. The in vitro transfection efficiencies of some acylated CPPs exceed those of the commercially available transfection reagents as LipofectAMINE ® .
The in vivo oligonucleotide delivery has been also improved.
The introduction of hydrocarbon moieties has opened new avenues in the design of vectors that may be used for drug targeting. We will review the various strategies, which have been developed to improve the delivery properties of CPPs. Most importantly, we will discuss their benefit for the delivery of small molecules, oligonucleotides and nanoparticles, in vitro and in vivo. for electrostatic repulsion oligolysines would be only partially protonated). To minimize the charge repulsion, binding energy of arginine side-chain and anions will be much stronger than for isolated arginines. [33] As a consequence, these polyarginines will always be surrounded by counteranions. C) Direct translocation in the presence of PyB. The counteranion might participate to the translocation transition state and enhance the rate of its formation.
Amphiphilic counteranions increase the transporter function of CPPs
As a proof of concept, the delivery of enhanced green fluorescent protein (GFP, 30 kDa) and of 15 The delivery of bioactive compounds is much more demanding because it requires to reach a specific target.
The effect of the counteranion-mediated delivery of CPP-bioactive cargo has been analyzed for the delivery of the pro-apoptotic domain peptide (PAD peptide) and for a splice-switching oligonucleotide. 
PyB-mediated CPP translocation has been first proposed and investigated using membrane models
It is fascinating to realize that this concept was first investigated with bulk membranes made of chloroform and artificial membrane bilayers before being applied to living cells. This is one important success of the bottom-up approach using model membranes.
The This information is relevant due to the presence of complex sulfated polysaccharides on cell surface (the glycosaminoglycans).
The translocation of oligoarginines does not correspond solely to a transfer of the peptide from the aqueous phase to the hydrophobic core of the membrane, but to a phase transfer followed by a reverse phase transfer from chloroform to the aqueous phase. The adaptability of the oligoarginines environment was monitored as the transfer across bulk membranes. This experiment enlightened the role of hydrophilic counteranions, which are able to exchange rapidly with the lipophilic counteranion, allowing a successful transfer across the bulk membrane. Such "activator" counteranions would promote the direct translocation pathway. The association between oligolysines and similar counteranions would be much weaker because i) all the lysine residues are not protonated at physiological pH, and ii) the absence of the bidentate hydrogen bonding observed with the guanidinium side-chain (Figure 2 A) . Among the various counteranions that have been tested, PyB turns to be the most successful activator of translocation on living cells. [28, 29] The counteranion-mediated translocation enhancement has one major drawback: it requires a serum-free medium and is thus not applicable to enhance in vivo drug delivery. Nevertheless, hydrophobic counteranions remain very useful for the in vitro delivery of small peptides as well as large proteins and might be used as adjuvants.
Lipidated CPPs as versatile vectors
Myristoylation and palmitoylation of proteins are natural post-translational modifications, which enhance membrane association of cytoplasmic proteins. [37, 38] In pharmacology, the addition of a lipid anchor is a general strategy that is currently in use to concentrate on cell surface peptides targeting membrane proteins. [39, 40] Moreover, it was found in the early 1990s that the myristoylation of some basic peptides enhanced their penetration. [41, 42] Since then, this strategy has been flourishing. [43, 44] Interestingly, the enhanced thermodynamic stability of oligonucleotide-lipopeptide complexes was already reported with acylated antimicrobial peptides, as well as the non-covalent successful delivery of oligonucleotides. [45, 46] The mechanisms of cell internalization of acylated peptides and the physico-chemical properties required for the acyl chain (quantity, in-cell distribution, low membrane perturbation) are still rather vague and need to be refined. But, it was ascertained that the presence of both cationic residues and a fatty acid moiety are necessary for the internalization. [47] Acylation of a neutral peptide does not increase its cellular uptake. [48] Even if acylation or farnesylation of a peptide is not sufficient to yield a stable anchoring to a membrane, the presence of both a cationic domain and an acyl chain cooperatively promotes membrane affinity. [49, 50] The acylation of the usual CPPs at their N-terminus can be easily performed on solid support; only the acylation with acid-sensitive hydrocarbons remains problematic because of the acidic cleavage conditions.
We will briefly review the synthesis procedures of CPPs modified with an acyl chain, before focusing on the successful use of lipopeptides for both in vitro and in vivo delivery of various cargoes. We will systematically discuss the internalization mechanisms of hydrocarbon-enhanced CPP drug delivery.
General strategies for the lipidation of CPPs
The N-terminal addition of a saturated fatty acid moiety is the most frequent derivatization ( A) The N-terminal introduction of a saturated hydrocarbon moiety can be directly performed on solid support (top). Alternatively a modified Schotten-Baumann reaction can be performed in solution followed by an amide bond formation (middle). [55] A stable carbamate bond is formed, when cholesterol was reacted as cholesteryl chloroformate with the N-terminal amine in solution (bottom). [57] B) The N-terminal acyl chain might participate to the translocation transition state and enhance the rate of this spontaneous internalization pathway.
Towards the internalization mechanism(s) of lipidated oligoarginines
Oligoarginine CPPs have a very high affinity for surface glycosaminoglycans, but a lower affinity for the outer leaflet of eukaryotic membranes. [27] In the first reports on the derivatizations of oligoarginines with hydrocarbon moieties, it was clearly stated that the acylation must enhance membrane affinity, and subsequently the internalization ability.
[54] Indeed, the primary amphipathic character induced by the addition of a lipid tail to non-amphipathic or secondary amphipathic CPPs favors the association of the CPP to the membrane. This increase in cellular association might result in an increase of the endocytic uptake.
But, the acyl chain might also trigger direct translocation, by participating and eventually facilitating the direct translocation transition state: the inverted micelle (Figure 3 B) .
The structures of the oligoarginine LPAs that were synthesized for the mechanistic studies are similar: a fatty acid covalently associated to the N-terminus of the peptide and a fluorophore coupled to the side-chain of the C-terminal amino acid. The influence of the number of arginines and the fatty acid chain length were both investigated. The affinity of the LPAs for the plasma membrane generally increases with the number of arginines and with the acyl chain length, the association with cell surface being 10 times larger for myristoyl-Arg11 than for Arg7 or Tat CPPs.
[54] The influence of these parameters on the internalization are more difficult to rationalize, and it is impossible to reach an evident trend. Nevertheless, it is clear that the acylation of oligoarginine CPPs increases dramatically their penetration ability into different cell lines, [48] even a short acyl chain (hexanoyl) enhances the internalization. [52] If most of the lipopeptides do not affect cell viability, LPA with long acyl chains and especially long oligoarginines (13 or 15 arginine residues) are slightly cytotoxic. [48, 48, 52] At a concentration below 10 µM, most of the cells incubated with fluorescent Arg8 or Tat CPPs exhibit a punctate fluorescence, which is attributed to a confinement of the CPPs inside endosomes and thus to energy-dependent uptake mechanisms. In contrast, the fluorescence of acylated oligoarginines with short acyl chains is more diffuse in the cytosol, being also present in the nucleus (short chains = myristoyl chains and shorter). [48, 52] However, punctate fluorescence is still observed. A co-localization with subcellular compartment such as the Golgi apparatus and the reticulum has also been proposed, related to the high affinity of LPA for membranes.
[54] The fluorescence between the different cells is also not homogeneous, in contrast with the observations made with the PyB counteranion strategy. This heterogeneous cell internalization was interpreted for Tat and Arg9 as a threshold effect. [31] More detailed insights into the internalization mechanisms were obtained using energy-dependent inhibitors (chemicals or temperature).
Oligoarginine CPPs, which are acylated by short chains, enter by both energy-dependent mechanisms and direct translocation, and both translocation pathways are enhanced in the presence of a fatty acid chain. [48, 52] Arg8 acylated with stearic acid enters via an energy-dependent pathway, as deduced from the low internalization at 4 °C, [60] probably related to the formation of large aggregates due to its low critical micelle concentration (CMC).
[61]
The number of arginine residues and the length of the acyl chain need to be optimized, depending on multiple factors such as cell line, cargo and targeted compartment. Nevertheless, acylated oligoarginines with the adjusted properties are promising delivery vectors, which have been successfully used for the in vitro and in vivo delivery of small molecules, proteins, and even nanoparticles.
Acylated oligoarginines as covalent small molecules, proteins and nanoparticles delivery vectors
Futaki et al. probed the delivery efficiency of these acylated oligoarginines. The PAD peptide, the small protein ubiquitin (9 kDa) or the larger carbonic anhydrase (29 kDa) were conjugated to the C-terminal cysteine side-chain of hexanoyl-Arg8 LPA. [52] The deliveries of these cargoes were increased in comparison to the one of the Arg8 conjugates, as estimated by confocal microscopy or by cell viability assay (proapoptiotic effect of PAD). This internalization enhancement cannot be translated to every cell type, meaning that this LPA requires further optimization for systemic delivery. Alternatively, its specificity might also be improved to target certain cell types.
Moore 
Acylated oligoarginines supramolecular assemblies as non-covalent small-molecules vectors
Dehsorkhi et al. recently published a very detailed review describing the great variety of nanostructures that can be obtained starting from self-assembling LPAs. [64] The nature of the hydrophobic core of a LPA governs size, shape, and aggregation of the self-assembled peptide-based nanostructures. By introducing different lipid structures it is possible to finely tune the properties of the supramolecular aggregates.
The self-assembly properties of a novel class of supramolecular building blocks in which the CPP Tat and a lipid dendrimer (possessing from 2 to 8 stearyl arms) are covalently bound were investigated by Lim et al. 
Acylated oligoarginines as non-covalent oligonucleotide vectors
Due to the high density of cationic residues, oligoarginine CPPs can bind and compact DNA. Complexes between Arg8 to Arg15 CPPs and DNA were prepared by mixing both entities and good transfection efficiencies were achieved. [51, 68] Nevertheless, complexes between short basic peptides and DNA are not very stable and an important amount of the complex remains trapped inside endosomes. [57, 69, 70] The acylation strategy circumvents the weakness of small peptides-oligonucleotides complexes. [46] N-terminal addition of fatty acids or cholesterol dramatically enhances the transfection efficiency of plasmid DNA compared to Arg8, as demonstrated by Futaki et al. [51] The most efficient LPA is stearyl-Arg8, whose transfection capability reaches the same order of magnitude than the one obtained with LipofectAMINE ® . The uptake of stearyl-Arg8-DNA complexes proceeds essentially, as expected, via endocytosis, given their size (∼ 100 nm). [60] The difference in transfection efficiency between stearyl-Arg8 and Arg8 has been interpreted as a difference in DNA compaction associated to: (i) the aggregation of the alkyl chains, and (ii) the enhancement of membrane interaction with the high number of alkyl chains presents in the stearyl-Arg8-DNA complex, both effects promoting endocytosis. Fluorescence confocal microscopy showed that the amount of internalized DNA was effectively increased in the presence of stearyl-Arg8 and that some of the DNA localized into the nucleus. [60] Stearyl-Arg8, as well as myristoyl-Arg7 and cholesteryl-Arg9, also enhances the uptake of TP10-oligonucleotide complexes are internalized, but the oligonucleotides remain trapped inside endosomes and chloroquine is required to enhance their endosomal escape. [53, 56] However, because of its toxicity, chloroquine cannot be used at high concentration for systemic application. The first modification that was introduced is the addition of a stearyl acyl chain at the N-terminus of TP10 (named PepFect3). This modification increases the internalization of a splice-correction oligonucleotide. But the addition of chloroquine again enhances the oligonucleotide delivery, demonstrating that a non-negligible fraction of oligonucleotide remains trapped into the endosomes. [53] PepFect6 is the next generation, with a lysine side-chain modified by a small dendrimeric structure of chloroquine derivatives whose role is to enhance endosomal escape without the need of adding chloroquine.
Stable PepFect6-siRNA complexes promote the in vitro and in vivo delivery of siRNA followed by the desired gene silencing in various organs. [73] The non-covalent delivery properties were enhanced by finely tuning the amino acid side-chains of PepFect3 to afford PepFect15. [74, 75] Lipidation of the existing CPPs is a promising strategy that allows some tuning of their initial properties.
Depending on the acyl chain length, direct translocation and/or energy-dependent internalization mechanisms can be enhanced. Most importantly, the delivery of various cargoes covalently or noncovalently associated to the lipidated CPP was increased. This strategy has even been successfully applied to in vivo oligonucleotides delivery via non-covalent LPA-oligonucleotides complexes. These complexes are stable enough to circulate in the bloodstream and to preserve the oligonucleotides from nuclease activity but also sufficiently labile to release oligonucleotides in the cytosol or the nucleus.
However, LPAs have some drawbacks. Because of their amphiphilic nature, their HPLC purification may be challenging. Their solubility may be low resulting in unstable concentrated stock solution. Moreover, an optimization of both the CPP and the fatty acid moiety has to be performed depending on the physicochemical properties of the cargo and on the subcellular localization of the target. Up to now as for CPP, "predictive properties" remains The issue. As a consequence, it might be interesting to design minimalist lipopeptides, whose synthesis can be performed in a few steps on solid support or even in solution.
Modification of the structure of acylated arginine-rich CPPs. En route for minimalist Trojan carriers
Enhancing the hydrophobic contribution of the interaction between CPPs and the plasma membrane can induce passive uptake, probably by increasing the association of the peptide with the membrane via the PLs tail. Understanding how the balance of hydrophobic and electrostatic interactions controls CPP-membrane interactions and, hence, membrane translocation may be the clue for designing new CPPs with specific membrane activity. [77] In the following sections, different structures of acylated cationic peptides will be presented and their related applications will be discussed.
Short cationic peptides amphiphiles
The chemical, physical, and biological properties of short cationic LPAs can be controlled by manipulating the chain length of the peptidic backbones, the amino acids sequence and the nature of the hydrocarbon (Figure 4 B) . They showed that a LPA containing one arginine and two lysines acylated by two palmitoyl acyl chains was able deliver into the cytoplasm a fluorescently labeled drug and a phosphopeptide. The endocytotic traffic was hypothesized to be the major internalization pathway. [79] Cationic lipids bearing lysine, arginine or histidine headgroups have been explored and used for plasmid DNA delivery and gene transfection. Interestingly, these LPAs self-assemble into large unilamellar vesicles Cyclisation of the cationic domain has been investigated to increase the proteolytic stability of the lipopeptides. The efficiency of acylated polycationic cyclic penta-and hexapeptides was evaluated.
Dodecanoyl-[Arg6]
, with an acyl chain bound to a Lys residue of the cyclic peptide, was the most potent for shuffling into cells a cell-impermeable phosphopeptide (Figure 4 C) . The internalization mechanism was found to be energy-dependent. [80] Furthermore, the screening of libraries of dynamic amphiphiles as delivery vehicles can be a convenient approach to identify new lipopeptides as siRNA transfecting agents.
[85]
The hydrophobic component can be introduced by using unnatural aminoacids
Arginine-rich CPPs, like (Arg-X-Arg) n peptides, where X is a generic carbon chain spacer, have been designed. The insertion of non-natural aminoacids, such as 6-aminohexanoic acid (Ahx), is expected to increase the metabolic stability. Wender et al. reported that Ahx seems to be optimal spacer for cellular uptake. [86] (Arg-Ahx-Arg) 4 can deliver phosphoramidate morpholinooligonucleotides (PMO) within HeLa cells, an (Arg-Ahx-Arg) 4 -PMO conjugates (Figure 4 D) led to a high splicing correction efficiency. [81] Similarly, the stearyl-(Arg-Ahx-Arg) 4 peptide was found to be very efficient to convey antisense splicecorrecting oligonucleotide in the HeLa cells. [87] In Lys-Ado-Arg-Ado-Arg anchors the membrane via favorable hydrophobic interactions and is able to penetrate into the bilayer inducing phase separation, permeabilization, and disruption of the membrane. [90] The success of minimalist Trojan carriers in delivering various cargoes opens new perspective because their structure can be finely tuned. By adjusting the properties of the carrier, virtually all the desired cargoes might be delivered.
Acylated oligoarginines mediate the internalization of multifunctional liposome-based delivery platform
Liposomes with an average diameter of 100-200 nm are widely investigated in nanomedicine as drug delivery agents: convenient processes have been successfully developed to efficiently load drugs in their lumen, functionalization of the surface with PEG moieties increased their circulation lifetime in the bloodstream. [91] Similarly as other high molecular weight and long-circulating nanoparticles, they have a high propensity to accumulate in the interstitial space of solid tumors via the so-called "enhanced permeability and retention effect" (EPR effect). [92, 93] High loading and passive targeting improve the drug specificity and efficiency and PEGylated liposomes are now being used clinically. [94] The modification of the liposomal surface with CPPs as an attractive strategy to exploit the penetration properties of CPPs to improve liposomes uptake will be described. Furthermore, internal trafficking issues will be discussed.
The concept of multifunctional envelope-type nanodevices
Harashima Finally, for the coating of the lipid-DNA particle with CPP, the stearylated-Arg8 is added as a solution in buffer, and the mixture incubated at room temperature (see Figure 5 for a schematic representation of a MEND).
Kogure et al. developed a MEND encapsulating pDNA to be tested as a novel non-viral gene delivery system. They found that the incorporation of stearylated-Arg8 in the lipid envelope confers attractive penetration properties to the liposome and enhances transfection activities as well as low cytotoxicity. [96] Later on, they developed a MEND, still decorated with stearyl-Arg8, in which the encapsulated siRNA is condensed with the spermatozoal peptide protamine. This MEND was designed to deliver to the nucleus 
Targeted multifunctional envelope-type nanodevices
Nanoparticles also passively target the encapsulated molecules to pathological tissues. To increase the selectivity, dual-ligand based PEG-liposomes were designed. 
The mechanisms of internalization and endosomal escape of liposomes are crucial issues
The endosomal escape is a crucial issue and can be induced by the presence of pH-sensitive lipids in the lipid envelope, while the nuclear translocation can be achieved by attaching a nuclear localization system (NLS) to the encapsulated pDNA.
Akita et al. set up a method to quantitatively analyze the intracellular distribution of rhodamine-labeled pDNA and the consequent efficacy of the transgene expression with sequential Z-series images captured by confocal microscopy. They showed that a MEND encapsulating pDNA decorated with stearyl-Arg8 on the surface exhibits endosomal escape and nuclear translocation, but lower than LipofectAMINE ® . The efficacy of LipofectAMINE ® transfection is presumably related to a rapid endosomal escape (cytoplasmic pDNA levels are severely decreased at 4 °C). [102] Later on, the same authors have described how the stearyl-Arg8 modification of liposomes and MENDs can influence the cellular uptake pathways. They report a shift of the uptake mechanism from a clathrin-mediated endocytosis, in the case of low stearyl-Arg8 density, to a macropinocytosis-mediated uptake of liposomes with a high stearyl-Arg8 density. [103] The macropinocytosis-mediated uptake provides a reduced lysosomal degradation hence influencing the intracellular trafficking and resulting in an enhanced gene expression. [103, 104] El-Sayed et al., investigated the role of cell-penetrating sequences decorating the surface of liposomes with respect to the cytosolic release pathway. In fact, high-density octaarginine-and octalysine-modified liposomes are both taken up primarily via macropinocytosis but then have different modes of escape from endosomes. Stearyl-Arg8 stimulates efficient escape from endocytotic vesicles via a fusion mechanism between the liposomes and the endosomal membrane that works at both neutral and acidic pH. On the contrary, stearyl-Lys8 mediates the escape only at neutral pH. As a consequence, stearyl-Arg8 liposomes display an enhanced gene expression than Lys8-liposomes. [105] The mechanism of the cytoplasmic transport of stearyl-Arg8-liposomes seems to be determined by a microtubule-dependent transport. [106] To resume, properly decorated nanoparticles can be designed and applied for a successful targeted cancer therapy. All findings herein reported highlight how the cytosolic trafficking events are a crucial issue and, once dissected, can be used to tune the intracellular targeting.
Summary and Conclusion
The addition of a hydrophobic moiety to the sequence of polycationic CPPs dramatically expands the scope of their application as drug delivery agent. Whereas CPPs are usually used as covalent (single molecule) vectors or as non-covalent poorly defined CPP-cargo complexes, acylated CPPs can be conveniently used to create or decorate well-characterized supramolecular nanocarriers. Moreover, the variety of cargoes (small molecules, peptides, nucleic acid or proteins) that were delivered using acylated CPPs demonstrates the versatility of this strategy.
For in vitro applications, cationic CPPs can be conveniently used in combination with PyB to enhance the delivery efficiency of the cargo. Reversible complexation of the CPP by PyB temporarily reverses the polarity of the polycationic CPP and allows its transitory solubilization in the membrane bilayer. The CPP and its cargo can ultimately be released inside the cytosol. This strategy presents three important advantages: the cell population internalizes more homogeneously the cargo, higher intracellular concentration of the cargo might be reached and the direct translocation pathway is specifically enhanced.
Thus, a co-incubation in the presence of PyB as counteranion might result in an increased accessibility of the cargo to the cytosol. The high flexibility of this strategy makes it very suitable for the optimization of an in vitro delivery system based on cationic CPPs. Nevertheless, the formation of a weak ion pair between cationic residues and hydrophobic counteranions is required. This induces a high sensitivity to anionic competitors and the incubation has to proceeds in PBS buffer, representing an insurmountable barrier for further in vivo development.
Permanent change in the amphiphilic character of CPP can be induced by the covalent introduction of a hydrophobic chain. Contrary to the addition of hydrophobic counteranion, the covalent addition of a hydrophobic group to a polyarginine CPP dramatically and irreversibly changes its amphiphaticity: the nonamphipathic Arg9 or Tat peptides become primary amphipathic lipopeptides. The acylation of TP10 increases its primary amphipathic character. As a consequence, CPPs derivatized by hydrocarbons have a high propensity to aggregate in aqueous media. The supramolecular architecture of these aggregates can be finely tuned by changing the nature and the number of fatty acid chains. Interestingly these micelles have the CPP moieties exposed on the surface and a hydrophobic core that can be used to encapsulate hydrophobic drugs to be delivered. Anionic nucleic acids can be also delivered by non-covalent strategy. In this case, the aggregates formed simply by mixing the oligonucleotide with the lipopeptide are large and have never been fully characterized. The acylation of the CPP enhances the stability of the CPPoligonucleotide complex and its internalization. In such case the internalization occurs via an endocytic route and escape from lysosomes has been observed. Alternatively, if the lipopeptide remains monomeric in solution or if the aggregate is sufficiently labile to dissociate upon binding to the outer leaflet of the plasma membrane the acylated CPP can reach the cytosol via direct translocation. These general observations might help to design more efficient vectors depending on the most favorable pathway for the considered cargo.
Despite cell-penetrating lipopeptides are still not in commercial use, some of them can be already envisioned as substitutes of the LipofectAMINE ® reagent for the delivery in vitro delivery of oligonucleotides and might even increase the transfection efficiencies. [51, 74, 75] Because of their primary amphipathic structure, acylated cationic CPPs have been also used to decorate the surface of various objects such as vesicular nanocarriers. The CPP moiety itself is supposed to actively enhance the internalization of the vesicle platform via energy-dependent processes. Even if the role of acyl chain might be far more complex, for example during an eventual fusion with the endosomal membrane, it is always considered as a simple anchor to the membrane. Vesicular nanocarriers have the advantage to have a highly tunable surface and an active targeting units can be added to enhance the specificity and thus to compensate the major drawback of CPPs. Because the targeting unit and the CPP are distinct on the surface, both can be a priori independently optimized. To date, MENDs are the most integrated and versatile delivery system.
Similarly to CPP, a fine rationalization of the internalization properties of cationic lipopeptides is still lacking. In particular, biophysical experiments are now required to characterize the aggregation and the internalization properties of LPA in order to optimize their delivery properties or even to propose a rational design. Thus, the minimization of the chemical structure of LPA might be an attractive objective. Indeed, the pharmacomodulation of minimalist lipopeptides could be quicker to perform and their in-solution synthesis might be more cost-efficient. The peptidic moiety can be reduced down to 3-4 amino acids, even if such small sequences are themselves non-penetrating in the absence of a hydrophobic moiety. Issues in this research route will be the reduced solubility of the minimalist lipopeptides and their reduced interaction with the cell membrane.
